About NanoString Technologies (NASDAQ:NSTG)
NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and Pan Cancer and 360 gene expression, protein immune profiling, neuropathology and neuro-inflammation gene expression, autoimmune disease gene expression, nCounter Vantage 3D, miRNA expression, cancer copy number variation, and other gene expression panels. Further, the company offers nCounter-based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and nCounter Dx Analysis System and Prosigna molecular diagnostic test kits. It has collaboration with Celgene Corporation; Merck & Co., Inc.; Medivation, Inc.; and Astellas Pharma, Inc. The company was founded in 2003 and is headquartered in Seattle, Washington.
Industry, Sector and Symbol
Industry Biological products, except diagnostic
Trailing P/E Ratio-5.04
Forward P/E Ratio-3.37
Sales & Book Value
Annual Sales$114.90 million
Price / Sales2.08
Price / CashN/A
Book Value$1.58 per share
Price / Book5.95
EPS (Most Recent Fiscal Year)($1.84)
Return on Equity-129.90%
Return on Assets-32.06%
NanoString Technologies (NASDAQ:NSTG) Frequently Asked Questions
What is NanoString Technologies' stock symbol?
NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."
How were NanoString Technologies' earnings last quarter?
NanoString Technologies (NASDAQ:NSTG) issued its quarterly earnings results on Wednesday, March, 7th. The biotechnology company reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.42) by $0.08. The biotechnology company earned $35.20 million during the quarter, compared to analysts' expectations of $31.57 million. NanoString Technologies had a negative return on equity of 129.90% and a negative net margin of 37.91%. The business's quarterly revenue was up 39.7% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.55) earnings per share. View NanoString Technologies' Earnings History.
When is NanoString Technologies' next earnings date?
What guidance has NanoString Technologies issued on next quarter's earnings?
NanoString Technologies issued an update on its FY18 earnings guidance on Wednesday, March, 7th. The company provided earnings per share (EPS) guidance of (2.90)-($2.60) for the period, compared to the Thomson Reuters consensus estimate of ($2.48).
What price target have analysts set for NSTG?
4 brokerages have issued 12 month price targets for NanoString Technologies' stock. Their forecasts range from $12.00 to $20.00. On average, they expect NanoString Technologies' stock price to reach $14.6667 in the next year. View Analyst Ratings for NanoString Technologies.
Who are some of NanoString Technologies' key competitors?
Some companies that are related to NanoString Technologies include PDL Biopharma (PDLI), Solid Biosciences (SLDB), Vericel (VCEL), Nightstar Therapeutics (NITE), Agenus (AGEN), Cellular Biomedicine Gr (CBMG), Idera Pharmaceuticals (IDRA), Adverum Biotechnologies (ADVM), NantKwest (NK), Allena Pharmaceuticals (ALNA), Osiris Therapeutics (OSIR), Fennec Pharmaceuticals (FENC), Arsanis (ASNS), ADMA Biologics (ADMA), Compugen (CGEN), Pluristem Therapeutics (PSTI), Organovo (ONVO) and Eiger Biopharmaceuticals (EIGR).
Who are NanoString Technologies' key executives?
NanoString Technologies' management team includes the folowing people:
- Mr. R. Bradley Gray, CEO, Pres & Director (Age 41)
- Mr. David W. Ghesquiere, Sr. VP of Corp. & Bus. Devel. (Age 51)
- Mr. K. Thomas Bailey, CFO, Treasurer & Principal Accounting Officer (Age 49)
- Dr. Mary Tedd Allen Ph.D., Sr. VP of Operations (Age 55)
- Mr. Douglas S. Farrell, VP of Investor Relations & Corp. Communications
Has NanoString Technologies been receiving favorable news coverage?
News articles about NSTG stock have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. NanoString Technologies earned a daily sentiment score of 0.03 on Accern's scale. They also gave headlines about the biotechnology company an impact score of 45.50 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of NanoString Technologies?
Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is NanoString Technologies' stock price today?
One share of NSTG stock can currently be purchased for approximately $9.39.
How big of a company is NanoString Technologies?
NanoString Technologies has a market capitalization of $236.09 million and generates $114.90 million in revenue each year. The biotechnology company earns $-43,560,000.00 in net income (profit) each year or ($1.84) on an earnings per share basis. NanoString Technologies employs 467 workers across the globe.
How can I contact NanoString Technologies?
NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The biotechnology company can be reached via phone at 206-378-6266 or via email at investor[email protected]
MarketBeat Community Rating for NanoString Technologies (NSTG)MarketBeat's community ratings are surveys of what our community members think about NanoString Technologies and other stocks. Vote "Outperform" if you believe NSTG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSTG will underperform the S&P 500 over the long term. You may vote once every thirty days.
NanoString Technologies (NASDAQ:NSTG) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
NanoString Technologies (NASDAQ NSTG) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 24.40%
Institutional Ownership Percentage: 91.97%
NanoString Technologies (NASDAQ NSTG) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/13/2018||William Young||Director||Buy||30,000||$6.91||$207,300.00||30,000|| |
|11/13/2017||David W Ghesquiere||SVP||Sell||689||$8.14||$5,608.46||17,327|| |
|4/3/2017||R Bradley Gray||Insider||Sell||1,100||$20.58||$22,638.00||75,785|| |
|12/6/2016||Wayne Burns||SVP||Sell||21,666||$22.04||$477,518.64||71,034|| |
|11/21/2016||Charles P Waite Jr||Director||Sell||588,024||$21.25||$12,495,510.00||1,707|| |
|11/11/2016||Barney Saunders||SVP||Sell||11,983||$22.48||$269,377.84||6,371|| |
|11/11/2016||James A Johnson||CFO||Sell||10,000||$22.57||$225,700.00||10,698|| |
|11/11/2016||R Bradley Gray||Insider||Sell||37,325||$22.49||$839,439.25||79,428|| |
|10/26/2016||Charles P Waite Jr||Director||Sell||42,489||$20.56||$873,573.84||1,707|| |
|9/8/2016||Charles P Waite Jr||Director||Sell||29,105||$16.51||$480,523.55||1,707|| |
|9/7/2016||Wayne Burns||SVP||Sell||3,961||$16.50||$65,356.50||59,704|| |
|8/30/2016||Charles P Waite Jr||Director||Sell||111,060||$16.57||$1,840,264.20||1,707|| |
|8/25/2016||Charles P Waite Jr||Director||Sell||40,363||$16.59||$669,622.17||1,707|| |
|8/22/2016||Charles P Waite Jr||Director||Sell||72,145||$16.61||$1,198,328.45||1,707|| |
|8/16/2016||Charles P Waite Jr||Director||Sell||257,698||$16.55||$4,264,901.90||1,707|| |
|3/2/2016||David W Ghesquiere||SVP||Sell||1,321||$14.86||$19,630.06||2,521|| |
|8/13/2015||Wayne Burns||SVP||Sell||30,000||$14.93||$447,900.00|| |
|12/2/2014||Barney Saunders||SVP||Sell||30,000||$14.93||$447,900.00|| |
|11/14/2014||Charles P Waite Jr||Director||Sell||14,632||$12.25||$179,242.00|| |
|9/8/2014||Charles P Waite Jr||Director||Sell||45,000||$11.21||$504,450.00|| |
|9/5/2014||Charles P Waite Jr||Director||Sell||86,942||$11.17||$971,142.14|| |
|9/3/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||35,000||$11.15||$390,250.00|| |
|8/19/2014||Charles P Waite Jr||Director||Sell||1,700||$12.01||$20,417.00|| |
|8/19/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||20,257||$12.05||$244,096.85|| |
|8/18/2014||Charles P Waite Jr||Director||Sell||18,557||$12.05||$223,611.85|| |
|8/18/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||11,925||$12.05||$143,696.25|| |
|8/15/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||28,801||$12.36||$355,980.36|| |
|6/13/2014||Charles P Waite Jr||Director||Sell||166,755||$15.08||$2,514,665.40|| |
|6/13/2014||Wayne Burns||SVP||Sell||4,900||$15.01||$73,549.00|| |
|6/12/2014||Barney Saunders||SVP||Sell||28,000||$15.04||$421,120.00|| |
|6/10/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||160,000||$15.48||$2,476,800.00|| |
|6/9/2014||Wayne Burns||SVP||Sell||20,100||$15.76||$316,776.00|| |
|7/1/2013||Lifesciences Ii L.P. Clarus||Major Shareholder||Buy||750,000||$10.00||$7,500,000.00|| |
NanoString Technologies (NASDAQ NSTG) News Headlines
|$21.48 Million in Sales Expected for NanoString Technologies (NSTG) This Quarter|
www.americanbankingnews.com - April 23 at 4:34 AM
| Brokerages Expect NanoString Technologies (NSTG) to Post -$0.76 EPS|
www.americanbankingnews.com - April 21 at 7:54 AM
|What does NanoString Technologies Inc’s (NASDAQ:NSTG) Balance Sheet Tell Us About Its Future?|
finance.yahoo.com - April 20 at 8:17 AM
|NanoString Technologies (NSTG) Rating Lowered to Sell at ValuEngine|
www.americanbankingnews.com - April 18 at 4:44 PM
|NanoString Technologies (NSTG) Lifted to "Hold" at Zacks Investment Research|
www.americanbankingnews.com - April 16 at 3:37 PM
|NanoString Technologies (NSTG) Upgraded to Buy by Zacks Investment Research|
www.americanbankingnews.com - April 11 at 5:35 PM
|NanoString Announces Launch of Breast Cancer 360 Research Panel, Expanding the 360 Series of Cancer Panels for Translational Research and Signature Development|
finance.yahoo.com - April 10 at 5:34 PM
|NanoString to Release First Quarter 2018 Financial Results and Host Conference Call on Tuesday, May|
www.nasdaq.com - April 9 at 8:12 AM
|NanoString Technologies (NSTG) Downgraded by Zacks Investment Research to Sell|
www.americanbankingnews.com - April 7 at 12:39 AM
|$21.90 Million in Sales Expected for NanoString Technologies (NSTG) This Quarter|
www.americanbankingnews.com - April 6 at 3:58 AM
|NanoString Technologies (NSTG) Given Average Recommendation of "Hold" by Brokerages|
www.americanbankingnews.com - April 5 at 11:15 AM
|-$0.77 Earnings Per Share Expected for NanoString Technologies (NSTG) This Quarter|
www.americanbankingnews.com - April 4 at 9:33 AM
|NanoString Technologies (NSTG) Upgraded to "Hold" at Zacks Investment Research|
www.americanbankingnews.com - April 1 at 12:58 PM
|NanoString Technologies (NSTG) Downgraded by Zacks Investment Research to "Hold"|
www.americanbankingnews.com - March 29 at 12:00 AM
|Zacks: Analysts Expect NanoString Technologies Inc (NSTG) Will Announce Quarterly Sales of $21.90 Million|
www.americanbankingnews.com - March 20 at 7:52 AM
|Edited Transcript of NSTG earnings conference call or presentation 7-Mar-18 9:30pm GMT|
finance.yahoo.com - March 18 at 8:12 AM
|NanoString Technologies Inc (NSTG) Director William Young Acquires 30,000 Shares|
www.americanbankingnews.com - March 14 at 7:49 PM
|NanoString Technologies Inc (NSTG) Receives Average Rating of "Hold" from Brokerages|
www.americanbankingnews.com - March 11 at 10:52 AM
|Morgan Stanley Trims NanoString Technologies (NSTG) Target Price to $12.00|
www.americanbankingnews.com - March 8 at 6:41 PM
|NanoString Technologies (NSTG) Issues Earnings Results, Beats Estimates By $0.08 EPS|
www.americanbankingnews.com - March 8 at 10:29 AM
|NanoString Technologies Releases Fourth Quarter and Full Year 2017 Operating Results and Provides 2018 Outlook|
finance.yahoo.com - March 7 at 6:40 PM
|NanoString Technologies (NSTG) Issues FY18 Earnings Guidance|
www.americanbankingnews.com - March 7 at 5:21 PM
|Should You Buy NanoString Technologies Inc (NASDAQ:NSTG) At $6.49?|
finance.yahoo.com - March 7 at 8:11 AM
|NanoString to Present at the 38th Annual Cowen Healthcare Conference|
finance.yahoo.com - March 6 at 5:45 PM
|Spark Investment Management LLC Sells 178,300 Shares of NanoString Technologies Inc (NSTG)|
www.americanbankingnews.com - March 3 at 12:36 PM
|Zacks: Brokerages Anticipate NanoString Technologies Inc (NSTG) Will Announce Quarterly Sales of $30.32 Million|
www.americanbankingnews.com - March 3 at 12:04 PM
|Altrinsic Global Advisors LLC Buys 170,000 Shares of NanoString Technologies Inc (NSTG)|
www.americanbankingnews.com - March 2 at 4:10 AM
|NanoString Technologies (NSTG) Set to Announce Quarterly Earnings on Wednesday|
www.americanbankingnews.com - February 28 at 3:14 AM
|ARK Investment Management LLC Has $8.51 Million Stake in NanoString Technologies Inc (NSTG)|
www.americanbankingnews.com - February 26 at 5:08 AM
|NanoString Technologies to Release Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call on Wednesday, March 7, 2018|
finance.yahoo.com - February 21 at 8:15 AM
|NanoString Technologies (NSTG) Scheduled to Post Quarterly Earnings on Tuesday|
www.americanbankingnews.com - February 20 at 4:14 AM
|NanoString Technologies Inc (NSTG) Given Average Rating of "Hold" by Analysts|
www.americanbankingnews.com - February 14 at 11:06 AM
|NanoString Technologies Inc (NSTG) Expected to Announce Quarterly Sales of $30.32 Million|
www.americanbankingnews.com - February 14 at 5:06 AM
|NanoString Showcases Groundbreaking New Platforms at 2018 Advances in Genome Biology and Technology (AGBT) Conference|
finance.yahoo.com - February 12 at 9:06 AM
|NanoString Technologies (NSTG) Says Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology|
www.streetinsider.com - February 7 at 8:51 AM
|NanoString Announces Largest and Most Comprehensive Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology|
finance.yahoo.com - February 6 at 8:49 AM
|NanoString Technologies (NSTG) Lowered to Strong Sell at ValuEngine|
www.americanbankingnews.com - February 4 at 7:40 PM
|Zacks: Analysts Expect NanoString Technologies Inc (NSTG) Will Post Earnings of -$0.43 Per Share|
www.americanbankingnews.com - January 26 at 1:24 PM
|New Research: Key Drivers of Growth for NanoString Technologies, Oaktree Capital Group, Midstates Petroleum, GlycoMimetics, State Street, and Retail Properties of America — Factors of Influence, Major Initiatives and Sustained Production|
finance.yahoo.com - January 26 at 8:37 AM
|NanoString Reports Inducement Grant Under NASDAQ Listing Rules|
finance.yahoo.com - January 20 at 9:31 AM
|NanoString Appoints Thomas Bailey as Chief Financial Officer|
finance.yahoo.com - January 16 at 9:29 AM
|$30.32 Million in Sales Expected for NanoString Technologies Inc (NSTG) This Quarter|
www.americanbankingnews.com - January 11 at 7:02 AM
| Brokerages Anticipate NanoString Technologies Inc (NSTG) Will Announce Earnings of -$0.48 Per Share|
www.americanbankingnews.com - January 9 at 11:34 AM
|NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017|
finance.yahoo.com - January 8 at 9:48 AM
|NanoString Technologies (NSTG) Stock Rating Upgraded by Zacks Investment Research|
www.americanbankingnews.com - January 3 at 1:20 PM
|NanoString Technologies, Inc. :NSTG-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018|
finance.yahoo.com - January 1 at 9:24 AM
|Head to Head Review: NanoString Technologies (NSTG) vs. IRIS International (IRIS)|
www.americanbankingnews.com - December 29 at 1:18 PM
|ETFs with exposure to NanoString Technologies, Inc. : December 28, 2017|
finance.yahoo.com - December 28 at 4:46 PM
|NanoString Technologies Inc (NSTG) Given Consensus Rating of "Hold" by Analysts|
www.americanbankingnews.com - December 26 at 9:52 AM
|NanoString Technologies Inc (NSTG) Expected to Announce Earnings of -$0.48 Per Share|
www.americanbankingnews.com - December 24 at 1:08 AM
NanoString Technologies (NASDAQ:NSTG) SEC Filings
This page is loading this company's SEC Filings. Please wait...
NanoString Technologies (NASDAQ:NSTG) Income Statement, Balance Sheet and Cash Flow Statement
NanoString Technologies (NASDAQ NSTG) Stock Chart for Monday, April, 23, 2018